IFP Advisors Inc trimmed its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 30.8% during the 1st quarter, HoldingsChannel reports. The firm owned 456 shares of the biopharmaceutical company’s stock after selling 203 shares during the period. IFP Advisors Inc’s holdings in Alnylam Pharmaceuticals were worth $46,000 as of its most recent filing […]
Endurant Capital Management LP purchased a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 4,596 shares of the biopharmaceutical company’s stock, valued at approximately $1,092,000. A number of […]
The Manufacturers Life Insurance Company decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 59.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 343,220 shares of the biopharmaceutical company’s stock after selling 495,795 shares during the quarter. […]
American Century Companies Inc. grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 1.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 699,795 shares of the biopharmaceutical company’s stock after acquiring an additional 6,788 shares […]
Simplify Asset Management Inc. lifted its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 8.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,392 shares of the biopharmaceutical company’s stock after purchasing an additional 112 shares during the period. Simplify […]